Neil Stahl, EVP Research and Development at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,664 shares at $339.53 ($1.6M) on 2019-11-08, disclosed to the SEC on 2019-11-12.
Open-market sale of $1.6M REGN by EVP Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $337.41 | 1,500 | $506K | 32.0% |
| 2 | $339.53 | 1,100 | $373K | 23.6% |
| 3 | $340.48 | 2,064 | $703K | 44.4% |
| Total | $339.27 avg | 4,664 | $1.6M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |